Who are Oxytocin 5 Usp Units In Dextrose 5%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Oxytocin versus oxytocin-ergometrine, Carbetocin infusion, Syntommetrine and Carbetocin, Standard Dose Synthetic Pitocin, Carbetocin bolus, Argipressin.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/oxytocin.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Oxytocin 5 Usp Units In Dextrose 5% — Competitive Intelligence Brief

Oxytocin 5 Usp Units In Dextrose 5% (OXYTOCIN) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Adrenocorticotropic Hormone [EPC]. Area: Neuroscience.

marketed Adrenocorticotropic Hormone [EPC] Oxytocin receptor Neuroscience Recombinant protein Live · refreshed every 30 min

Target snapshot

Oxytocin 5 Usp Units In Dextrose 5% (OXYTOCIN) — Fresenius Kabi.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Oxytocin 5 Usp Units In Dextrose 5% TARGET	OXYTOCIN	Fresenius Kabi	marketed	Adrenocorticotropic Hormone [EPC]	Oxytocin receptor	1980-01-01
Oxytocin versus oxytocin-ergometrine	Oxytocin versus oxytocin-ergometrine	Hadassah Medical Organization	marketed	Uterotonic agent	Oxytocin receptor (OXTR); ergometrine acts on alpha-adrenergic and serotonin receptors
Carbetocin infusion	Carbetocin infusion	Ciusss de L'Est de l'Île de Montréal	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Syntommetrine and Carbetocin	Syntommetrine and Carbetocin	National University Hospital, Singapore	marketed	Uterotonic agent	Oxytocin receptor
Standard Dose Synthetic Pitocin	Standard Dose Synthetic Pitocin	Weill Medical College of Cornell University	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Carbetocin bolus	Carbetocin bolus	Ciusss de L'Est de l'Île de Montréal	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Argipressin	Argipressin	Kristina Svennerholm	marketed		Oxytocin receptor, Vasopressin V1a receptor, Vasopressin V1b receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Adrenocorticotropic Hormone [EPC] class)

· 2 drugs in this class
Guna spa · 2 drugs in this class
Bracco · 1 drug in this class
Fresenius Kabi · 1 drug in this class
Sanofi · 1 drug in this class
Mallinckrodt Ireland · 1 drug in this class
QUESTCOR PHARMA · 1 drug in this class
Rad Neurim Pharmaceuticals Eec Sarl · 1 drug in this class
Amphastar Pharms Inc · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oxytocin 5 Usp Units In Dextrose 5% — Competitive Intelligence Brief. https://druglandscape.com/ci/oxytocin. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab